9hon MSN
Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program
Q4 2025 Management View CEO Joseph Ciaffoni stated that 2025 was a transition year, highlighting the successful completion of ...
Indivior Pharmaceuticals, Inc. ( INDV) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Good morning, everyone. I am joined today by Joe Ciaffoni, Chief Executive Officer; Pat Barry, Chief ...
The federal government is investing in a new program to help Canadian defence and dual-use technology startups develop, refine and sell their products in the country and beyond as Canada accelerates ...
The CRN 2026 Partner Program Guide includes software vendor partner programs that are designated 5-Star programs.
ITHACA, N.Y., Feb. 26, 2026 /PRNewswire/ — Rev: Ithaca Startup Works announces the launch of applications for its 2026 Prototyping Hardware Accelerator, a summer-long program that guides entrepreneurs ...
Canada announced $8 million in accelerated humanitarian aid for Cuba on Wednesday, as the island nation battles rolling ...
Dubai, UAE – The Mohammed Bin Rashid Innovation Fund (MBRIF), an initiative launched by the Ministry of Finance to support ...
The Frontier BioHealth program is intended to get startup founders ready to pitch to investors and secure funding. Current ...
Over the past few years, Falcorp has delivered cloud-led transformation projects focused on improving operational efficiency ...
As the Army accelerates its acquisition reform processes and structures, the Pathway for Innovation and Technology, is designed to ...
Be prepared … or risk annoying the gatekeeper. Imugene’s experience with the FDA shows how regulatory polish can shave years off a drug’s path to approval.
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results